BRIEF-Merck CEO says tax inversion deals would not fit its corporate strategy
September 09, 2014 at 08:38 AM EDT
Sept 9 (Reuters) - Merck & Co Inc : * Merck CEO, at Morgan Stanley Global Healthcare Conference, says tax inversion deals would not fit its corporate strategy * CEO says tax inversion benefit would require overly large transaction * CEO says changes needed to make U.S. tax rate more competitive, but may not